Otsuka Pakistan Limited (PSX:OTSU)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
277.20
-4.65 (-1.65%)
At close: Jul 18, 2025

Otsuka Pakistan Company Description

Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.

The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, and proten gold; and therapeutic drugs, which include pletaal and mucosta tablets, as well as oral rehydration therapy supplement for urinary tract.

It engages in the trading of pharmaceutical products, nutritional foods, and medical equipment. Further, the company provides medical devices, including Made in Germany CE-marked drug-eluting coronary stents, PTCA balloon catheters, and other coronary angioplasty accessories and electrophysiology products.

Otsuka Pakistan Limited was incorporated in 1988 and is headquartered in Karachi, Pakistan.

Otsuka Pakistan Limited
CountryPakistan
Founded1988
IndustryPharmaceuticals
SectorHealthcare
Employees345
CEOMoin-ur Rehman

Contact Details

Address:
30-B
Karachi, 74400
Pakistan
Phone92 21 3452 8651
Websiteotsuka.pk

Stock Details

Ticker SymbolOTSU
ExchangePakistan Stock Exchange
Fiscal YearJuly - June
Reporting CurrencyPKR
ISIN NumberPK0038001019
SIC Code2834

Key Executives

NamePosition
Moin-ur RehmanChief Executive Officer
Tauseef ShaikhChief Financial Officer